BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4725477)

  • 1. Focal necrotizing glomerulonephritis: treatment with prednisone and chlorambucil.
    Johnson JR; McGovern VJ; May J; Lauer C
    Med J Aust; 1973 Jul; 2(1):9-12. PubMed ID: 4725477
    [No Abstract]   [Full Text] [Related]  

  • 2. Focal necrotizing glomerulonephritis.
    Johnson JR; McGovern VJ
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):749-68. PubMed ID: 4803316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C; Passerini P
    Minerva Urol Nefrol; 1984; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H
    Munch Med Wochenschr; 1969 Aug; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognosis and treatment of membranous nephropathy.
    Ponticelli C
    Kidney Int; 1986 Apr; 29(4):927-40. PubMed ID: 2940407
    [No Abstract]   [Full Text] [Related]  

  • 6. [Course of nephropathy in systemic lupus erythematosus . Influence of the treatment on clinical symptoms, renal function and histology].
    Zech P; Richard P; Blanc-Brunat N; Labeeuw M; Colon S; Pozet N; Dupont E; Fries D; Traeger J
    J Urol Nephrol (Paris); 1972 Dec; 78(12):987-93. PubMed ID: 4540960
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recovery of normal ultrastructure in 2 cases of primary glomerulonephritis with diffuse extra-membranous deposits].
    Bariéty J; Samarcq P; Lagrue G; Fritel D; Milliez P
    Presse Med (1893); 1968 Nov; 76(46):2179-82. PubMed ID: 4888396
    [No Abstract]   [Full Text] [Related]  

  • 8. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable outcome in diffuse proliferative glomerulonephritis of systemic lupus erythematosus.
    Epstein WV; Grausz H
    Arthritis Rheum; 1974; 17(2):129-42. PubMed ID: 4131150
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid.
    Dussol B; Kaplanski G; Daniel L; Brunet P; Pellissier JF; Berland Y
    Nephrol Dial Transplant; 1998 Oct; 13(10):2630-2. PubMed ID: 9794573
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of primary chronic glomerulonephritis with a triple combination of prednisone, azathioprine and a nitrogen mustard derivative].
    Traver JA; Guajardo DS; Botella J
    Rev Clin Esp; 1975 May; 137(4):321-5. PubMed ID: 1144863
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic membranoproliferative (mesangiocapillary) glomerulonephritis: a clinicopathologic study.
    Donadio JV; Slack TK; Holley KE; Ilstrup DM
    Mayo Clin Proc; 1979 Mar; 54(3):141-50. PubMed ID: 431120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed cryoglobulins and glomerulonephritis.
    Golde D; Epstein W
    Ann Intern Med; 1968 Dec; 69(6):1221-7. PubMed ID: 4177812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current therapeutic possibilities in chronic idiopathic glomerulonephritis].
    Ponticelli C; Fogazzi GB
    Minerva Urol Nefrol; 1985; 37(1):9-12. PubMed ID: 3901338
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of the nephrotic syndrome with the aid of immunosuppressive drugs].
    Zosin C; Mănescu N; Schwarzkopf A
    Med Interna (Bucur); 1967 Sep; 19(9):1067-75. PubMed ID: 6064760
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednisone therapy of membranoproliferative glomerulonephritis in children.
    Warady BA; Guggenheim SJ; Sedman A; Lum GM
    J Pediatr; 1985 Nov; 107(5):702-7. PubMed ID: 3903090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid and immunosuppressive treatment in glomerulonephritis. (Literature review).
    Alatas H
    Paediatr Indones; 1974; 14(7-8):135-42. PubMed ID: 4617177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.